Camurus announces positive results from POSITANO phase 2b study of octreotide SC depot in patients with symptomatic polycystic liver disease: Lund, Sweden Thursday, June 19, 2025, ...

UK study suggests that patients with prolactinoma treated with dopamine agonists are more likely to develop impulse control disorders ...

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be discussed with regulatory authoritiesLUND ...

Camurus (NASDAQ STO: CAMX) today announced topline results from the 12-month, randomized, double-blind, placebo-controlled POSITANO Phase ...

Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...

THE HEALTH CARE SYSTEM, ALONG WITH THE COMPANY HIPPOCRATIC AI, ROLLED OUT THE PHONE BASED CONVERSATIONAL AI IN SEPTEMBER AS A WAY TO REACH OUT TO PATIENTS. MY INITIAL THOUGHT WAS SCAM. LORI ...

6. Several in-hospital therapies that have historically been used to treat patients with ICH appear to confer either no benefit or harm. For emergency or critical care treatment of ICH, prophylactic ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...

To protect the safety of employees, patients, visitors, and students, the health care system has no choice but to cease operations at this location without delay. As a result, as of 7 a.m ...

If passed, the "One Big Beautiful Bill Act" will prohibit Medicaid funds from going to Planned Parenthood. The "One Big, Beautiful Bill Act" could block Medicaid funds from going to Planned Parenthood ...

Significantly fewer Hispanic patients received preferred first-line treatment for CLL vs. white patients. Use of preferred first-line treatment also varied by practice type. CHICAGO ...